The pathogenesis of Infant ALL is still not well defined. Short latency to leukemia and very high concordance rate for ALL in MLL-positive infant twins suggest that the MLL rearrangement itself could be sufficient for overt leukemia. Attempts to generate a suitable mouse model for MLL-AF4 positive ALL did not thoroughly resolve whether cooperating mutations are required to reduce latency and generate overt leukemia in vivo. In this study, we applied SNP-array technology to perform genomic profiling of 28 Infant ALL cases carrying t(4;11) with the purpose to detect MLL-cooperating aberrations hidden to conventional techniques and gain new insights into Infant ALL pathogenesis. In contrast to pediatric, adolescent and adult ALL cases, MLL rea...
Abstract Background The presence of MLL rearrangements in acute leukemia results in a complex number...
Includes 3 unnumbered pages at the end of the article. Published online 2 March 2015Infant acute lym...
Although advances in the treatment of childhood acute lymphoblastic leukaemia (ALL) mean that about ...
Mice models and prenatal studies indicate that in childhood ALL the individual genetic lesions alone...
Mice models and prenatal studies indicate that in childhood ALL the individual genetic lesions alone...
Infant B-cell acute lymphoblastic leukemia (B-ALL) accounts for 10% of childhood ALL. The genetic ha...
Infant B-cell acute lymphoblastic leukemia (B-ALL) accounts for 10% of childhood ALL. The genetic ha...
Infant B-cell acute lymphoblastic leukemia (B-ALL) accounts for 10% of childhood ALL. The genetic ha...
Although 90% of children with acute lymphoblastic leukemia (ALL) are now cured, the prognosis for in...
Infant acute lymphoblastic leukemia (ALL) with MLL rearrangements (MLL-R) represents a distinct leuk...
Distinct from most other acute lymphoblastic leukemia (ALL), infant ALL with mixed lineage leukemia ...
<p>117 cases of infant acute lymphoblastic leukemia without Down syndrome (aged from 1 to 365 days) ...
Aim. To evaluate the relation between genomic DNA breakpoints in MLL and translocation partner genes...
textabstractAcute lymphoblastic leukemia (ALL) in infants (< 1 year) is characterized by a poor prog...
Acute lymphoblastic leukemia (ALL) in infants (< 1 year) is characterized by a poor prognosis and...
Abstract Background The presence of MLL rearrangements in acute leukemia results in a complex number...
Includes 3 unnumbered pages at the end of the article. Published online 2 March 2015Infant acute lym...
Although advances in the treatment of childhood acute lymphoblastic leukaemia (ALL) mean that about ...
Mice models and prenatal studies indicate that in childhood ALL the individual genetic lesions alone...
Mice models and prenatal studies indicate that in childhood ALL the individual genetic lesions alone...
Infant B-cell acute lymphoblastic leukemia (B-ALL) accounts for 10% of childhood ALL. The genetic ha...
Infant B-cell acute lymphoblastic leukemia (B-ALL) accounts for 10% of childhood ALL. The genetic ha...
Infant B-cell acute lymphoblastic leukemia (B-ALL) accounts for 10% of childhood ALL. The genetic ha...
Although 90% of children with acute lymphoblastic leukemia (ALL) are now cured, the prognosis for in...
Infant acute lymphoblastic leukemia (ALL) with MLL rearrangements (MLL-R) represents a distinct leuk...
Distinct from most other acute lymphoblastic leukemia (ALL), infant ALL with mixed lineage leukemia ...
<p>117 cases of infant acute lymphoblastic leukemia without Down syndrome (aged from 1 to 365 days) ...
Aim. To evaluate the relation between genomic DNA breakpoints in MLL and translocation partner genes...
textabstractAcute lymphoblastic leukemia (ALL) in infants (< 1 year) is characterized by a poor prog...
Acute lymphoblastic leukemia (ALL) in infants (< 1 year) is characterized by a poor prognosis and...
Abstract Background The presence of MLL rearrangements in acute leukemia results in a complex number...
Includes 3 unnumbered pages at the end of the article. Published online 2 March 2015Infant acute lym...
Although advances in the treatment of childhood acute lymphoblastic leukaemia (ALL) mean that about ...